Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Shares Issued (2023 - 2025)

Historic Shares Issued for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $352000.0.

  • Inhibrx Biosciences' Shares Issued changed N/A to $352000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $352000.0, marking a year-over-year decrease of 9950.89%. This contributed to the annual value of $71.7 million for FY2024, which is 6416.1% down from last year.
  • Latest data reveals that Inhibrx Biosciences reported Shares Issued of $352000.0 as of Q3 2025.
  • In the past 5 years, Inhibrx Biosciences' Shares Issued ranged from a high of $198.8 million in Q3 2023 and a low of $352000.0 during Q3 2025
  • Its 3-year average for Shares Issued is $67.7 million, with a median of $35.8 million in 2024.